• 1. Heats of hydrogenation of large molecules. Part 3.—Five simple unsaturated triglycerides (triacylglycerols)
  Donald W. Rogers,Debendra N. Choudhury J. Chem. Soc. Faraday Trans. 1 1978 74 2868

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Triacylglycerols
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Triradylcglycerols Triacylglycerols

Recent Advances in the Study of 6-Octadecenoic Acid,1,1',1''-(1,2,3-Propanetriyl) Ester, (6Z,6'Z,6''Z)- (CAS: 3296-43-3)

In recent years, the compound 6-Octadecenoic acid,1,1',1''-(1,2,3-propanetriyl) ester, (6Z,6'Z,6''Z)- (CAS: 3296-43-3) has garnered significant attention in the field of chemical biology and pharmaceutical research. This triglyceride derivative, characterized by its unique unsaturated fatty acid chains, has shown promising potential in various biomedical applications, including drug delivery systems, lipid metabolism modulation, and anti-inflammatory therapies. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its chemical properties, biological activities, and potential therapeutic applications.

The chemical structure of 6-Octadecenoic acid,1,1',1''-(1,2,3-propanetriyl) ester, (6Z,6'Z,6''Z)- features three (6Z)-octadecenoic acid moieties esterified to a glycerol backbone. This configuration imparts distinct physicochemical properties, such as enhanced solubility in lipid-based matrices and improved stability under physiological conditions. Recent studies have focused on optimizing the synthesis of this compound to achieve higher yields and purity, which are critical for its application in pharmaceutical formulations. Advanced chromatographic techniques, including HPLC and GC-MS, have been employed to characterize and quantify the compound in complex biological matrices.

One of the most notable findings in recent research is the compound's role in modulating lipid metabolism. In vitro and in vivo studies have demonstrated that 6-Octadecenoic acid,1,1',1''-(1,2,3-propanetriyl) ester, (6Z,6'Z,6''Z)- can influence the activity of key enzymes involved in fatty acid oxidation and synthesis. For instance, it has been shown to upregulate peroxisome proliferator-activated receptors (PPARs), which play a pivotal role in lipid homeostasis. These findings suggest potential applications in the treatment of metabolic disorders such as obesity and type 2 diabetes.

Additionally, the anti-inflammatory properties of this compound have been extensively investigated. Research indicates that it can inhibit the production of pro-inflammatory cytokines, such as TNF-α and IL-6, by suppressing the NF-κB signaling pathway. This mechanism underscores its potential as a therapeutic agent for chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. Furthermore, its biocompatibility and low toxicity profile make it an attractive candidate for long-term therapeutic use.

In the realm of drug delivery, 6-Octadecenoic acid,1,1',1''-(1,2,3-propanetriyl) ester, (6Z,6'Z,6''Z)- has been explored as a carrier for hydrophobic drugs. Its ability to form stable micelles and liposomes enhances the solubility and bioavailability of poorly water-soluble drugs. Recent studies have successfully encapsulated chemotherapeutic agents within these lipid-based carriers, demonstrating improved tumor targeting and reduced systemic toxicity in preclinical models. These advancements hold significant promise for the development of next-generation nanomedicines.

Despite these promising findings, challenges remain in the clinical translation of this compound. Issues such as scalability of synthesis, long-term stability, and precise mechanism of action require further investigation. Ongoing research aims to address these gaps through multidisciplinary approaches, combining chemical synthesis, molecular biology, and pharmacokinetic studies. Collaborative efforts between academia and industry are expected to accelerate the development of this compound into viable therapeutic options.

In conclusion, 6-Octadecenoic acid,1,1',1''-(1,2,3-propanetriyl) ester, (6Z,6'Z,6''Z)- (CAS: 3296-43-3) represents a versatile and promising molecule in chemical biology and pharmaceutical research. Its unique chemical structure and diverse biological activities offer numerous opportunities for therapeutic innovation. Continued research and development efforts are essential to fully unlock its potential and translate these findings into clinical applications that benefit patients worldwide.

• 1338-43-8(Span-80)
• 9005-70-3(Tween 85)
• 25496-72-4(Glycerol Monoleate)
• 26266-58-0(Sorbitane Trioleate)
• 111-03-5(rac 1-Oleoyl Glycerol)
• 101-34-8(Glyceryl Triacetoricinoleate)
• 26303-90-2(4-Decenoic acid)
• 122-32-7(Glycerine Trioleate)
• 8001-79-4(Castor oil)
• 15818-46-9(1,3-Glyceryl Dilinoleate (>80%))